戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                                  We describe how to use 3View for studying collagen fibril organizati
2  "specification problem") and the problem of how to use a computer to simulate the progress of the sy
3  psychoeducational intervention, were taught how to use a pillbox, and were given written instruction
4                             Finally, we show how to use a reference fluorophore for the correction of
5            Before grasping and demonstrating how to use a specific tool, participants passively viewe
6                In this protocol, we describe how to use a time-correlated single-photon counting (TCS
7                         Finally, we describe how to use a user-friendly and easily accessible web ser
8                             The challenge is how to use advanced molecular understanding with limited
9 developing the ability of the brain to learn how to use an implant may be as important as further imp
10               The focus of this review is on how to use and apply microarrays to these situations.
11 ecreased?" Their findings leave us uncertain how to use and interpret these measures to track changes
12 ation was not independent of tumor features, how to use BRAF V600E to manage mortality risk in patien
13 lines provide conflicting recommendations on how to use bronchodilators to manage childhood acute whe
14 ng approach more appropriate for determining how to use chromatography most efficiently in one's own
15                 This protocol also describes how to use confocal microscopy to visualize mitophagy in
16                 In this protocol, we discuss how to use data obtained in affinity purification-mass s
17                       This protocol explains how to use DAVID, a high-throughput and integrated data-
18 r fluids adequately to a transplant patient; how to use direct vasoactive agents; how to manage the i
19 o provide guidance to oncology clinicians on how to use effective communication to optimize the patie
20       In this paper, the authors demonstrate how to use empirical methods appropriate for EBQP tables
21    At the same time, critical information on how to use established drugs like nelfinavir and efavire
22                          Finally, we outline how to use exosomes to efficiently deliver siRNA in vitr
23                      Although strategies for how to use guidelines to improve care are increasingly w
24 iders seek guidance from economic studies on how to use health care resources wisely.
25                                  We describe how to use hidden Markov models to evaluate multilocus t
26                           Our approach shows how to use high-throughput data to calculate accurately
27 his note we provide a step-to-step guide for how to use HIVcleave to identify the cleavage sites of a
28                                      We show how to use information theory to validate simple stimulu
29 rce code of the program and documentation on how to use it are freely available to non-commercial use
30 rception as probabilistic inference, we show how to use knowledge of the psychophysical task to make
31 an introduction for scientific experts about how to use mental models research with intended audience
32                      This protocol describes how to use microengraving to screen mouse hybridomas to
33 red their personal experiences and advice on how to use modeling effectively.
34  newer areas of inquiry attempting to define how to use molecular-genetic features of individual tumo
35                                We illustrate how to use our model to examine previously uncharacteriz
36                            Moreover, we show how to use our package to easily perform Connectivity Ma
37                In this protocol, we describe how to use our previously reported gelatin-based O2-cont
38  from plants and provide recommendations for how to use our results.
39    Thus, MBBC users are not required to know how to use Ox, R or C++, but they must be pre-installed.
40 been studied for 200 years, understanding of how to use parallel flows to augment the capabilities of
41 ers and clinicians should carefully consider how to use PFS data in balancing potential benefits agai
42                                  We describe how to use PLINK, a tool for handling SNP data, to perfo
43                                    We detail how to use prior knowledge to bound the number of detect
44                   In this paper, we describe how to use PROBEmer, the computational methods it employ
45 ticle, we provide a step-by-step guidance on how to use PS methods.
46                                  We describe how to use public protein databases and molecular modeli
47                A Readme file, which explains how to use pViz with examples, is available as Supplemen
48    In addition, new video tutorials describe how to use RDP features.
49 rrent work-up of lymphocytosis and highlight how to use recently identified prognostic tools to strat
50                                      We show how to use reference 450k datasets to estimate cell type
51                                      We show how to use relativistic motion to generate continuous va
52 icians and patients are often confused about how to use results of studies in individual cases.
53 s an overview of the algorithm and describes how to use Scalpel to perform highly accurate indel call
54                 In this protocol we describe how to use several popular features of Vaa3D, including
55                    In this protocol, we show how to use small-scale transient transfection and fluore
56 ich entrants submitted strategies specifying how to use social learning and its asocial alternative (
57 inding sites, suggesting that adjustments of how to use such metrics are required.
58                                Here, we show how to use suffix array-based methods that have formed t
59                      As we continue to learn how to use targeted therapies in the context of genomic
60 nonlinear interactions, but it was not clear how to use that information to obtain quantitative insig
61                              Here, we detail how to use the 'novel tank' test to assess behavioral in
62        We present a set of protocols showing how to use the 3DNA suite of programs to analyze, rebuil
63                               We demonstrate how to use the computational environment R to integrate
64 entists, a step-by-step guide is provided on how to use the current web server to generate their desi
65  of when to order testing, what to order and how to use the data in real time remains an area for fut
66                                  Examples of how to use the database to identify Drosophila genes rel
67 njector is prescribed, education on when and how to use the device should be provided.
68 erstands the concept of occupancy factor and how to use the dosing charts, our model facilitates appl
69  when and how to introduce fluorine but also how to use the effects of fluorine for a desirable resul
70  exists in each marker interval, we describe how to use the expectation-maximization algorithm to exa
71  interval at most one crossover, we describe how to use the expectation-maximization algorithm to exa
72                                      We show how to use the expectation-maximization algorithm to fin
73 l as its recent development, particularly in how to use the general formulation of PseAAC to reflect
74             Not all participants could learn how to use the Icare HOME device, but for those who coul
75                         This protocol covers how to use the intrinsic circular dichroic properties of
76                                  We describe how to use the Kimura distribution in mitochondrial gene
77                             Finally, we show how to use the library to extract SWATH data with the op
78 n of the method and give several examples of how to use the modules in specific cases.
79                             The authors show how to use the MSM parameter estimates and contrasts to
80                       In particular, we show how to use the multigeneration-wrinkled substrate for se
81 beled coalescent tree (PLCT) and demonstrate how to use the PLCT to evaluate the feasibility of a gen
82                     The user can quickly see how to use the pressure for speed or for more theoretica
83  effector transgenes in tissues of interest, how to use the Q system in conjunction with the GAL4 sys
84 ssues will be experimentally manipulated and how to use the Q system to perform mosaic analysis.
85  assays has led to potential confusion about how to use the results for clinical decision making.
86  forward, one of the many challenges will be how to use the results of molecular profiling to guide p
87                 Extensive video tutorials on how to use the site are available through http://www.met
88 inst new viral strains is vital for deciding how to use the stockpile.
89 ish SoNar-expressing cells, and then discuss how to use the system to quantify the intracellular redo
90  the reader will find a brief description on how to use the various scripts and programs.
91                      This protocol describes how to use the viral protein families catalog ( approxim
92 entists, a step-by-step guide is provided on how to use the web server to obtain the desired results
93     This protocol is a step-by-step guide on how to use the Web-server predictors in the Cell-PLoc pa
94  step-by-step protocol guide was provided on how to use the web-server to get the desired results wit
95 ibe how these human-powered systems work and how to use them effectively in scientific domains.
96  and insect cells as well as instructions on how to use them in stable isotope dilution mass spectrom
97 benefit our studies of individual genes, and how to use them to improve our understanding of developm
98 est suit their needs, where to get them, and how to use them to their best advantage.
99 d synthesis, as well as practical details of how to use them with living cells.
100 ral-fluid-based HIV test kits, instructed on how to use them, and encouraged to distribute a test kit
101 rmative resources for scientists-IF you know how to use them.
102 ed them rather than clear instructions about how to use them.
103                             As an example of how to use these approaches, in this article we use a co
104                                     However, how to use these biomarkers is still being debated, espe
105 eractions were analyzed to better understand how to use these characteristics to extract how biomolec
106 our objective was to provide a framework for how to use these data correctly in a spatial meta-popula
107                                              How to use these databases effectively is an open questi
108 e already established, guidance is needed on how to use these drugs in patients already receiving ant
109 ment between health care providers regarding how to use these indices.
110                      Clinicians need to know how to use these modalities and monitor them properly, e
111           We conclude with considerations on how to use these new agents to treat non-AIDS-defining c
112                              We then discuss how to use these parameters in the optimal design of pea
113 e such as PLINK, R or Haploview, we describe how to use these popular tools for handling single-nucle
114 everal other FST estimators, and we describe how to use these statistics to produce a rooted tree of
115 tegies have shown promise, but guidelines on how to use these strategies optimally are lacking.
116     We also presented a framework to outline how to use these three algorithms to obtain collaborativ
117                      This protocol describes how to use this approach to determine how efficiently a
118                          Finally, we outline how to use this approach to investigate which targets po
119 ers, and will hopefully provide insight into how to use this biomarker more productively by distingui
120 rotocol we describe the synthesis of CS1 and how to use this chemical tool to investigate intracellul
121 ol, we describe the synthesis of MitoPY1 and how to use this chemical tool to visualize mitochondrial
122 s to ascertain the source of vision loss and how to use this clinical information to help guide the s
123                              We further show how to use this framework to create simple models with a
124 sponsible for complex disease phenotypes and how to use this information to develop new and specific
125 Five case studies are provided to illustrate how to use this information to inform responses to real-
126                               We demonstrate how to use this knowledge to refine these methods and im
127 form, in vitro detection of ATP and GTP, and how to use this platform to realize intracellular ATP an
128                       A current challenge is how to use this structural information for the rational
129                      This protocol describes how to use this system, which provides a powerful tool f
130                      This protocol describes how to use this system; the time required for lysing the
131 linicians to have a fuller sense of when and how to use time-limited trials.
132            This protocol describes in detail how to use TopHat and Cufflinks to perform such analyses
133 itional mouse model of epilepsy, we describe how to use transcranial US to disrupt electrographic sei
134                            Here, we describe how to use Transmission Electron Microscope (TEM) to obt
135                 This review focuses first on how to use troponin, which at present is the best valida
136  domains of life and provides an example for how to use various experimental techniques to rapidly le

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top